Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host cell ribosome and translation machinery comprise the complex assembly of ribosomal RNAs (rRNA), ribosomal proteins, and auxiliary translation factors responsible for protein synthesis. In eukaryotic cells, the 80S ribosome decodes messenger RNA (mRNA) to catalyze the formation of polypeptide chains (Molecular Biology of the Cell, 2014). This machinery is a critical focal point for various pathogens, particularly viruses, which hijack host ribosomes to produce viral proteins at the expense of host cell function (Nature, 2020). Additionally, dysregulation of translation is a hallmark of many cancers, where increased protein synthesis supports rapid cell proliferation and survival (Cell, 2019). Therapeutic strategies targeting this machinery include small molecule inhibitors of translation initiation factors like eIF4A and elongation factors like eEF1A, as well as drugs like omacetaxine mepesuccinate that directly bind the ribosomal A-site (PubChem). Because translation is essential for all living cells, targeting this system requires careful management of systemic toxicity and off-target effects (Nature Reviews Drug Discovery, 2018).
Inhibition of the ribosomal A-site to prevent aminoacyl-tRNA positioning, inhibition of the eIF4F initiation complex, inhibition of eEF1A-mediated elongation, and site-specific rRNA depurination by ribosome-inactivating proteins.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell ribosome and translation machinery.